11555 Sorrento Valley Road
Suite 100
San Diego, CA 92121
United States
(858) 224-1000
https://www.organovo.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 18
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Keith E. Murphy | Executive Chairman | 762.74k | N/A | 1972 |
Mr. Thomas P. Hess CPA, MBA | President & CFO | 199.32k | N/A | 1964 |
Ms. Vaidehi Joshi | Director of Discovery Biology & Director | 91.8k | N/A | 1987 |
Dr. Curtis M. Tyree Ph.D. | Senior Vice President of Strategy & Business Development | N/A | N/A | N/A |
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.
Organovo Holdings, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.